These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2416822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae.
    Grossman N, Joiner KA, Frank MM, Leive L.
    J Immunol; 1986 Mar 15; 136(6):2208-15. PubMed ID: 3950413
    [Abstract] [Full Text] [Related]

  • 6. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella.
    Schweinle JE, Ezekowitz RA, Tenner AJ, Kuhlman M, Joiner KA.
    J Clin Invest; 1989 Dec 15; 84(6):1821-9. PubMed ID: 2592561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 10. Salmonella O antigen-specific oligosaccharide-octyl conjugates activate complement via the alternative pathway at different rates depending on the structure of the O antigen.
    Grossman N, Svenson SB, Leive L, Lindberg AA.
    Mol Immunol; 1990 Sep 15; 27(9):859-65. PubMed ID: 1699120
    [Abstract] [Full Text] [Related]

  • 11. [Chemical and serological characterization of Salmonella lipopolysaccharides from different phases of growth (author's transl)].
    Schlecht S, Fromme I.
    Zentralbl Bakteriol Orig A; 1975 Oct 15; 233(2):199-222. PubMed ID: 766501
    [Abstract] [Full Text] [Related]

  • 12. [Effect of the cultivation temperature on the production of biomass and lipopolysaccharide as well as the chemical composition and antigenicity of the lipopolysaccharide of S-forms and R-mutants of the genus Salmonella].
    Schlecht S.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Apr 15; 261(2):147-60. PubMed ID: 2426871
    [Abstract] [Full Text] [Related]

  • 13. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT, Bogard WC.
    J Immunol; 1987 Jul 15; 139(2):557-61. PubMed ID: 3298431
    [Abstract] [Full Text] [Related]

  • 14. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ, Grossman N, Leive L.
    J Immunol; 1983 Apr 15; 130(4):1867-70. PubMed ID: 6187823
    [Abstract] [Full Text] [Related]

  • 15. Functional characterization of WaaL, a ligase associated with linking O-antigen polysaccharide to the core of Pseudomonas aeruginosa lipopolysaccharide.
    Abeyrathne PD, Daniels C, Poon KK, Matewish MJ, Lam JS.
    J Bacteriol; 2005 May 15; 187(9):3002-12. PubMed ID: 15838026
    [Abstract] [Full Text] [Related]

  • 16. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W, Arabski M, Fudała R, Holmström E, Sjöholm A, Weintraub A, Futoma-Kołoch B, Bugla-Płoskońska G, Doroszkiewicz W.
    Arch Immunol Ther Exp (Warsz); 2009 May 15; 57(5):383-91. PubMed ID: 19707721
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA, Warren KA, Tam M, Frank MM.
    J Immunol; 1985 May 15; 134(5):3411-9. PubMed ID: 3920319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Construction of recombinant aroA salmonellae stably producing the Shigella dysenteriae serotype 1 O-antigen and structural characterization of the Salmonella/Shigella hybrid LPS.
    Fält IC, Mills D, Schweda EK, Timmis KN, Lindberg AA.
    Microb Pathog; 1996 Jan 15; 20(1):11-30. PubMed ID: 8692007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.